Effect of Glaucoma Educators on Adherence to Prescribed Therapeutic Regimens in Glaucoma Patients

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00454922

Enrollment

Registered

2007-04-02

Start date

2007-10-31

Completion date

2012-01-31

Last updated

2012-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Keywords

glaucoma, patient educator

Brief summary

Glaucoma is a leading cause of blindness worldwide. Non-adherence to glaucoma medication, which may result in loss of vision, is known to be prevalent. Available information regarding adherence to prescribed medical therapy suggests that some apparent treatment failures may actually be due to non-adherence. The investigators' specific aim is to conduct a study that will examine the effect of a glaucoma educator intervention on adherence to topical glaucoma therapy. The investigators' hypothesis is that patient education and counseling delivered by a trained glaucoma educator, through both planned visits and telephone contacts, will increase adherence to topical glaucoma therapy.

Interventions

BEHAVIORALstandard of care

no intervention

OTHEReducation

meet with trained glaucoma educator 6 times over life of study

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Diagnosis of primary or secondary open angle glaucoma. * Currently on monotherapy drop treatment for glaucoma. * Age \> 18 years. * Patient has presented for care at the Rocky Mountain Lions Eye Institute Glaucoma Center.

Exclusion criteria

* Inability to independently administer eye drops due to physical disability as reported by the patient. * Cognitive impairment that would interfere with the ability to self-administer medications as evidenced by a TICS score \< 16. * Patients who demonstrate \> 80% adherence to glaucoma treatment during the 30 day run-in period. * It is anticipated that the patient will require glaucoma surgery within the next six months.

Design outcomes

Primary

Measure	Time frame
primary outcome is adherence.	6 months

Secondary

Measure	Time frame
differences between patients randomized to standard of care and education intervention.	6 months
differences between dropouts and non-dropouts.	6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026